Health Canada drug identification number

DIN 02439123 — PROLENSA 0.07 %

PROLENSA is a solution of Bromfenac marketed by BAUSCH & LOMB INC. The full Bromfenac monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02439123
Brand name
PROLENSA
Active ingredient
Bromfenac
Strength
0.07 %
Dosage form
SOLUTION
Route
OPHTHALMIC
Manufacturer
BAUSCH & LOMB INC
Health Canada status
MARKETED
Drug class
Non-steroidal anti-inflammatory drug (NSAID), ophthalmic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Bromfenac products

DINBrandStrengthFormManufacturerStatus
02537788 APO-BROMFENAC 0.07 % SOLUTION APOTEX INC MARKETED
02540789 AURO-BROMFENAC 0.07 % SOLUTION AURO PHARMA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.